Title of Invention

LOW FOAMING CLEANER

Abstract Liquid compositions for cleaning, in particular medical instruments and air conditioning surfaces, said composition excluding surfactants and comprising one or more enzymes including a protease and optionally a hydrolase, a solvent system including a water soluble glycol ether solvent, at least one anionic hydrotrope, and wherein the molar ratio of said at least one hydrotrope to said glycol ether in the composition is selected to preserve the activity of said one or more enzymes. The hydrotrpe is advantageously an anionic hydrotrope selected from the group consisting of water soluble anionic hydrotropes of the formula: and having no alkyl side chain greater than six carbons in length, for example a xylene sulfonate or cumene sulfonate salt.
Full Text Field of the invention:
This invention relates to a composition for use for general cleaning, and in particular for
use in cleaning medical instruments and which is effective for soil removal and protein
digestion while remaining low foaming.
Background
The incidence has been widely reported of post procedural infections associated with
surgery or diagnostic studies. It is believed that a significant number of these infections
are due to inadequate reusable instrument reprocessing.
Cleaning of instruments on an industrial scale involves two steps. In the first step the
instrument is cleaned and in the second step it is disinfected normally to "high level
disinfection" or "sterilization" standards. It is generally accepted that failure to adequately
clean items after use in the first step may compromise the efficacy of the second. The
elimination of human proteins from the instruments represents a significant challenge.
The challenge has been made more difficult as medical instruments have been developed,
for example endoscopes, which utilize materials that are neither temperature resistant nor
chemically inert.
For effective cleaning of medical instruments a preparation should be effective for soil
removal, effective for protein digestion and resist foaming. In addition, the products are
required to have stability and a long shelf life.
These desiderata tend to be mutually inconsistent objectives. In order to avoid foaming,
soil removal preparations used in hospital cleaning/sterilizing "reprocessing" systems have
mainly utilized highly alkaline non-foaming detergents, but their use is incompatible with
both enzymes, and with materials of construction of flexible endoscopes. The use of close
to neutral "enzymatic detergents" (preparations including both enzymes and detergents)
has been found to be relatively effective for removal of proteins and safe with endoscopes,
and enables acceptable levels of soil removal to be achieved. However, while enzymes in
"enzymatic detergents" help to remove proteins, surfactants have been needed to remove

the fats and carbohydrates. Due to the incorporation of surfactants, "enzymatic detergents"
tend to produce foam to an unacceptable extent.
Foaming is undesirable because it blocks the visualization of instruments in manual
cleaning baths, impedes access of washing liquor to soils during manual cleaning and
blocks water jets and washing liquor circulation in automated washers (e.g. tunnel
washers). The foams tend to block the lumens of instruments preventing effective
cleaning of the lumen interior. When enzyme based cleaners have been used in
reprocessing machinery the foam tends to fill the volume thus impeding the cleaning cycle
by disrupting jets and agitation. Furthermore it makes the machine difficult to unload,
interfering with proper draining, and leaving foam residues containing pathogens which
can contaminate following cleaning cycles giving rise to significant risk of cross infection
since the cleaners do not kill the micro-organisms which they dislodge from surfaces.
Instruments covered with foam require additional handling and washing before they can
be sterilized. Increasingly the additional labour cost, time, and water consumption costs
are regarded as unacceptable. Multiple guidelines and standards recognise the problem
and warn against using foaming detergents for cleaning medical instruments (e.g. AS
4187:2003 or AS 4815:2006).
Although this problem has been recognized, it has not to date been satisfactorily
overcome. Two solutions to the foaming problem have been utilized, however to date
neither approach has succeeded in satisfying the market need.
In the first approach antifoams have been added to the cleaning composition or washer,
but that has been unsatisfactory because antifoams leave unacceptable residues on the
medical instruments. In the second approach attempts have been made to use so called
'•low foaming" non-ionic detergents such as alkylene oxide adducts. These tend to leave
an undesirable film of oily residue on treated surfaces similar to that from antifoams and
also produce hazy solutions which reduce visibility during washing cycles.
As a consequence commercially available formulations results tend to be either
inadequately cleansing, or high foaming, and thus not suitable for use for cleaning medical

instruments, or tend to be unstable and possess an inadequate shelf life, due to denaturing
of the enzymes by surfactants employed.
Cheetham (Australian Infection Control, Sept 2005,10, 3, p103-109) compared 17 market
leading enzyme based medical instrument cleaners from eight manufacturers (Table 1).

The products were tested using SDS - PAGE methodology to compare the molecular
weights of a group of standardised blood proteins before and after exposure to the various
cleaning products. Cheetham reported that half of the products tested, when used in
accordance with the manufacturers' directions, exhibited little or no protein digestion, and
only two of the products (Rapid 70500 and Rapid 70501 - both from 3M and also known
as RMEC 70500 and RMEC 70501 respectively) provided a high degree of protein
digestion. Cheetham did not report on foaming properties or stability. The present
Applicant has tested the two products which provided a high degree of protein digestion
and found that one exhibits high level of foaming while the other contains alkylene oxide
block copolymer and leaves undesirable oily residues on the treated surface. Moreover,

while both exhibit good stability with easily inhibited enzymes, both show poor stability
with difficult to inhibit enzymes.
Further, whilst the problem has been outlined with respect to cleaning medical
instruments, the desire for cleaning compositions which are efficacious in removing soil
and digesting proteins whilst resisting foaming is not limited to the field of cleaning
medical instruments. Such properties, along with stability and a long shelf life, are
desirable in many different cleaning applications.
A further area where low foaming cleaning compositions are desirable is in the area of air
conditioning and cooling. For instance, fresh food cool rooms have their temperature
controlled by a refrigeration unit fitted with fans which is integral with the room. The fans
draw environmental air through a refrigerated cooling coil heat exchanger into the room.
The process of cooling the air results in a lowering of humidity with the moisture being
condensed onto the cold surfaces of the heat exchanger. It is well known that any
environmental surface which is continually wet or damp will become covered in biofilm.
This biofilm not only reduces heat exchange efficiency, but is a very significant potential
source of microbiological contamination into the room and is therefore undesirable.
There currently only limited number of existing methods of removing biofilm from heat
exchange coils. The biofilm may be removed with abrasive brushes or high pressure
water. This has proved to be problematic because the spaces between the cooling fins are
insufficient to allow efficient brushing and the surface areas so extensive as to make this
brushing an extremely tedious process. High pressure water has proven to be undesirable
because it damages the cooling fins which are made of thin aluminium sections.
Alternatively, the heat exchange coil may be washed with strong alkali or strong acid.
This has proved to be problematic because the alkali or acid, whilst eventually removing
the biofilm both causes significant corrosive damage to the aluminium fins and the copper
refrigeration tubes to which they are attached. This corrosion severely limits the service
life of the heat exchange coil.

Thus, it is desirable to have effective yet non-corrosive cleaning agents that act without
producing large quantities of foam.
Any discussion of the prior art throughout the specification should in no way be
considered as an admission that such prior art is widely known or forms part of common
general knowledge in the field.
Object of the invention
It is an object of the present invention to provide an improved composition for cleaning,
and in particular cleaning medical instruments which avoids or ameliorates at least some
of the disadvantages of prior art. It is an object of preferred embodiments of the present
invention to provide a composition for cleaning, and in particular cleaning medical
instruments which is low foaming, has excellent enzyme shelf stability and is effective for
soil removal and protein digestion.
Brief Statement of invention.
The present invention provides liquid compositions which provide high levels of soil
removal, exhibit superior protease stability, and minimize foaming to acceptable levels
without leaving undesirable levels of residues. The compositions exhibit very high enzyme
shelf life stability.
In a broad aspect, the invention provides a liquid for cleaning, said composition excluding
surfactants and comprising one or more enzymes including a protease, a solvent system
including a water soluble glycol ether solvent, at least one anionic hydrotrope, and
wherein the molar ratio of said at least one hydrotrope to said glycol ether in the
composition is selected to preserve the activity of said one or more enzymes.
According to a first aspect the invention provides a liquid composition for cleaning
medical instruments, said composition excluding surfactants and comprising one or more
enzymes including a protease, a solvent system including a water soluble glycol ether
solvent, at least one anionic hydrotrope, and wherein the molar ratio of said at least one

hydrotrope to said glycol ether in the composition is selected to preserve the activity of
said one or more enzymes.
Unless the context clearly requires otherwise, throughout the description and the claims,
the words "comprise", "comprising", and the like are to be construed in an inclusive sense
as opposed to an exclusive or exhaustive sense; that is to say, in the sense of "including,
but not limited to".
In preferred embodiments the composition includes several additional hydrolase enzymes
in addition to a protease or proteases, said hydrolase enzymes including but not limited to
lipases, cellulases and amylases.
Desirably, the hydrotrope is an anionic hydrotrope selected from the group consisting of
water soluble anionic hydrotropes of the formula:

and more preferably of the formula

and having no alkyl side chain greater than six carbons in length.
In preferred hydrotropes R and R are independently alkyl groups of from 1 to six
carbons, although R1 or R2 may optionally be hydrogen. Preferred hydrotropes have a
short chain (less than six, and preferably from one to four carbons, and more preferably
from one to two carbons). Very highly preferred hydrotropes are water soluble xylene
sulfonate (R1 is methyl, R2 is methyl) and cumene sulfonate (R1 is isopropyl, R2 is
hydrogen) salts.

Since both anionic hydrotropes and glycol ether solvents are considered strong protein
(and enzyme) denaturing agents it is surprising that compositions according to the
invention possess all the above desiderata:
- non foaming
excellent enzyme shelf-life stability
excellent cleaning performance against standard medical soils,
leaves no undesirable residues
According to a second aspect the invention provides a composition according to the first
aspect wherein the molar ratio of hydrotope: glycol ether is selected to be greater than 1.1:
1. More preferably the weight ratio of hydrotope: glycol ether is greater than 1.2: lor
better still is greater than 1.5:1.
According to a third aspect the invention provides a composition according to the first or
second aspect in a concentrate adapted to be diluted for use by at least 20 parts of water to
1 part of the concentrate (100 to 1000 parts of water to 1 part of concentrate in preferred
embodiments) and wherein the hydrotrope is selected from the group comprising of water
soluble aromatic sulfonates with one or more short (C1-C6) side alkyl chains..
According to a fourth aspect the invention provides a composition according to the first or
second aspect wherein the solvent comprises in combination at least one glycol ether, at
least one polyhydric alcohol, and water containing boron or borate ions.
According to a fifth aspect the invention provides a composition according to any one of
the preceding aspects wherein each component of the composition is selected so as to
exclude compounds incorporating an alkyl chain of longer than six carbons.
The concentration ratios are critical for prevention of enzyme deterioration on storage.
The weight ratio of hydrotrope to proteolytic enzyme to should be between 400:1 and
200:1, more preferably 300:1 and 350:1 and the concentration of hydrotrope should not
exceed 25 %. The molar ratio of glycol ether to polyhydric alcohols is preferably between
0.2:1 and 1:1

The compositions of the present invention are particularly suited to cleaning medical
instruments, and have been principally described with reference to that use, however, it
will be appreciated that the cleaning compositions of the present invention are by no
means limited to that use. They may be used in any circumstances where it is desired to
clean biological matter from surfaces, including industrial and domestic applications, for
example, in cleaning down any wet surface contaminated with proteinaceous materials, or
cleaning refrigeration coils. The compositions of the present invention have been found to
be especially efficacious for cleaning the interior of cooling towers and the heat exchange
surfaces of heat exchange equipment involving water.
EXAMPLES:
Compositions according to the invention are shown in examples 1, 2, 3.
These differ from each other primarily in that the molar ratio of sodium xylene sulfonate
to glycol ether in the compositions is 1.1:1; 1.2:1 and 1.6:1 respectively.





In use, compositions according to the invention may be stored as concentrates for periods
of at least 18 months at 25°C and should be diluted by tap water from 20:1 to 1000:1
before use.
Table 2 below summarises the performance of the best of the compositions evaluated by
Cheetham as referred to above and identified in table 1. Table 2 compares in summary
form 12 commercially available cleaners in terms of shelf life protease stability (columns
2 and 3), soil removal efficacy (column 4), residual foam height (column 5) and presence
of potential residue. The three most effective commercially available compositions in
terms of soil removal were Cidezyme, 3M Rapid 70505 and 3M 70500 all of which scored
10. However, of these 3M Rapid 70500 produced a residual foam height of 500 ml which
is unacceptable, while 3M rapid 70505 left an oily residue which is also unsatisfactory.
The Cidezyme passed the residual foam height test without any residue. However
Cidezyme failed on both the stable and unstable proteases shelf life stability tests. In
comparison formulations according to examples 1, 2, 3 of the invention achieved excellent
soil removal and passed each of the tests.


Table 3 below shows the results for comparative examples 4 and 5. These examples differ
from examples 1 to 3 in that the molar ratio of hydrotrope to glycol ether is not selected to
preserve the activity of said one or more enzymes, and is below 1.0:1 and 0.9:1
respectively. This shows that to achieve stability for the compositions exemplified the
mole ratio of hydrotrope to glycol ether should be selected to be above 1.1:1. However
the ratio required to be selected could be determined for other compositions within the
scope of the invention having regard to the teachings herein disclosed.


Details of the tests used and results obtained to prepare the data in tables 2 and 3 above are
given below:
1. Soil removal test
Scope: This method allows for a qualitative and/or quantitative assessment of the relative
efficacy of cleaners and detergents in removing a simulated medical soil.
Browne indicator strips - STF load check indicators (Albert Browne Ltd Leicester UK) -
are designed to ensure and assist in documenting the cleaning efficacy of tunnel washers,
single chamber washer-disinfectors, etc. The indicator consists of a plastic substrate, with
a patch of protein-based soil applied to both sides. This simulates a very difficult to
remove medical soil. The amount of soil remaining on the strip after detergent treatment
can be assessed visually.
Preparation of samples for Soil removal test
125 ml beakers with 99±0.5 ml of tap water are placed in a water bath to equilibrate to
required temperature for approximately 30 minutes.
The required amount of test product/sample detergent is then added to each beaker and
stirred gently. One beaker is left as a control with the addition of 1ml of water instead of
test product. These solutions are left for a further 5 minutes to equilibrate to temperature.

Browne STF Load Check Indicator strips (Browne strip) are cut in half (to give two test
strips) and then added to each beaker. The dimensions of the beaker are selected to enable
the strip to be positioned at an angle whilst being fully submerged in the test solution.
At the end of the prescribed time interval the strips are carefully removed with clean
tweezers ensuring that no contact is made with the soiled patch on either side of the strip.
The strips were then dipped in clean tap water briefly and then allowed to drip dry. After
drying the strips are placed on white paper and photographed for visual assessment.
Estimation of the degree of soil removal
The degree of soil removal is generally measured on a scale of 0 to 10, with 0 being the
lowest degree (No visible soil removal) and 10 being the highest degree (complete soil
removal).
(b) Soil removal Results
The best commercially available enzymatic detergents (per Cheetham - see appended
table 1) were compared with formulations according to the invention using the soil
removal test described above with the results shown in Table 4.


2. Protease Shelf Life stability Tests
Scope: The test allows comparison of ingredients of enzymatic formulations in respect of
their ability to preserve protease activity during storage.
Enzymatic activity is known to decrease over time due to protein denaturing and auto-
proteolysis (self-digestion). These processes are dramatically accelerated by increase in
temperature - each 10 degrees temperature rise increases the rate of denaturing by up to 8
times. The loss of proteolytic activity over time is quantified for each product and
expressed as percentage for each formulation.
Procedure:
Denature any remaining protease in cleaners under study by gentle boiling of each product
for 2-3 min in a capped beaker,

1. Cool and confirm absence of proteolytic activity using protease test strips,
2. Add 10% w/w of test protease. In "Test A" a stable protease (Savinase Ultra 16XL,
from Novozymes) is used. In "Test B" a relatively unstable enzyme (Savinase 16L,
from Novazymes) is used. If practical, both the well stabilised and a poorly
stabilised enzyme are used in the same assay - e.g. Savinase Ultra 16XL AND
Savinase 16L from Novozymes.
3. Divide each prepared sample into three and store at 4, 25 and 40 °C
4. Assay and report initial protease activity
5. After 14 days assay remaining protease activity of each sample
Report the percentage of protease activity loss at each temperature.
A loss of 5% or less of initial protease activity for both stable and unstable proteases in
table 5 is regarded as a "pass".
(b) Results for stable and unstable protease shelf life tests.
The results obtained for each of the compositions listed in table 4 in respect of stable and
unstable Protease shelf life tests described above is shown in Table 5:



3 Foam volume test and Residue Presence tests
Principle (foam volume)
An increase in foam volume was determined by blending for 30 sees using a
commercial type blender with glass jar at 25 ± 1°C agitated at ~ 6000 rpm, and then
measuring the increase in total volume of test fluid including foam.
Apparatus
Blender: A Moulinex commercial blender was used. The glass jar was volume
graduated (20-25mL marks).
Procedure (foam volume)
1. Clean and rinse the blender with distilled water using 10s blends and fresh samples
of distilled water until blending develops no appreciable foam. If a foam persist, clean
with alcohol, followed by at least three rinses with distilled water.
2. Using the manufacturer's recommended dilutions prepare 500 ml of solution
3. Pour the test liquid into a clean glass bottle or jar and store it at 25°± 1°C for a
minimum of 1 h and a maximum of 2 h in the constant temperature water bath deep
enough so that the water level is at least 10 mm above the air/test fluid interface.
4. Pour the test liquid into the blender jar.
5. Measure and record the test liquid volume, disregarding any foam. Call this the
initial volume I.

6. Blend for 30 ± 1 s at selected speed.
7. Shut off the blender and immediately measure the total volume including foam.
Subtract initial volume of solution (I) and report as foam volume.
A residual foam height of less than 100 is accepted as a "pass".
Residue Presence Test
Scope: Report oily residues, if present.
Method: Oily residues can be easily observed on glass slides using dissecting microscope
and lateral lighting.
Pre cleaned microscope glass slides were dipped into diluted enzymatic cleaner and then
gently rinsed by dipping the slide once into a beaker with distilled water. The slide was
allowed to drip dry before assaying for presence of residues
Any detectable residue is a "fail". No detected residue is a "pass".
(b) Results for Residual Foam Volume and Residue Presence tests.
The results obtained for each of the compositions listed in table 4 in respect of the foam
volume test and residue presence test described above is shown in Table 6:



By way of further example, appended figures 1 - 4 illustrate differences in
foaming/residue properties. Figures 1-4 simulate normal usage procedures in which a
concentrate is measured into a container and then the required amount of water is added.
The result is photographed without stirring.
Figure 1 shows medical instruments in a container filled with 3M Rapid Multi enzyme
Cleaner 70500 - one of the two best performers in the Cheetham study. The instruments
are hardly visible because of foam.
Figure 2 shows the same product (3M Rapid Multi enzyme Cleaner 70500) in a beaker
with a stable volume of foam above the liquid.
Figure 3 shows the other of the best performers (3M Rapid 70505). A visible undesirable
milky residue is suspended in the cloudy liquid.
Figure 4 corresponds to figure 1 when a composition according to the invention (example
2) is employed.
In the compositions exemplified the ratios of hydrotrope to protease and of DPM to
polyhydric alcohols for each of the compositions is shown in table 7


Example 7 - Cleaning heat exchanger
The low foaming compositions of the present invention was used to clean a heat
exchanger. A two step process was employed.
Firstly the heat exchanger was sprayed with the enzymatic cleaner of the present invention
such as described in Examples 1-3 above. The enzymatic cleaner is typically diluted at a
rate of 50 parts water to 1 part enzymatic cleaner for very dirty heat exchangers and up to
100 parts of water to 1 part of enzymatic cleaner for less severely soiled heat exchangers.
The cleaner is allowed to soak into the contaminated surface in order to penetrate and
digest biological matter. The soaking period is typically between 10 and 20 minutes
depending on the depth of soil on the heat exchange surfaces.
Secondly, the heat exchanger was sprayed with low pressure water to remove the digested
contaminants without physical damage to the fins. The digested contaminants were
readily removed as the amount of foam obstruction of the coils was minimal.
This process was in contrast to carrying out the clearing with a conventional enzymatic
preparations which have a propensity to foam copiously during this spraying phase. The
foam suspends contaminant particles and hides from view the areas which require further
spraying.
Therefore the use of a very low foaming or non foaming enzymatic preparation has proved
to be greatly advantageous.
Although the invention has been described with reference to specific examples, the
formulations may be altered to an extent which will be apparent to those skilled in the art
from the teaching hereof without departing from the scope of the inventive concepts herein
disclosed.

WE CLAIM :
1. A liquid composition for cleaning, said composition excluding surfactants and
comprising one or more enzymes including a protease, a solvent system including a water
soluble glycol ether solvent, at least one anionic hydrotrope, and wherein the molar ratio
of said at least one hydrotrope to said glycol ether in the composition is selected to
preserve the activity of said one or more enzymes.
2. A liquid composition according to claim 1 wherein the composition includes
several additional hydrolase enzymes in addition to a protease or proteases, said hydrolase
enzymes including but not limited to lipases, cellulases and amylases.
3. A liquid composition according to claim 1 or claim 2 wherein, the hydrotrope is an
anionic hydrotrope selected from the group consisting of water soluble anionic
hydrotropes of the formula:

and having no alkyl side chain greater than six carbons in length.
4. A liquid composition according to claim 3 wherein, the hydrotrope is an anionic
hydrotrope selected from the group consisting of water soluble anionic hydrotropes of the
formula:
and having no alkyl side chain greater than six carbons in length.
5. A liquid composition according to any one of the preceding claims wherein R1 and
R2 are independently alkyl groups of from 1 to six carbons, although R1 or R2 may
optionally be hydrogen.

6. A liquid composition according to any one of the preceding claims wherein R1 and
R2 have a chain from one to four carbons.
7. A liquid composition according to any one of the preceding claims wherein R1 and
R2 have a chain from one to two carbons).
8. A liquid composition according to any one of the preceding claims wherein the
hydrotrope is xylene sulfonate or cumene sulfonate salts.
9. A liquid composition according to any one of the preceding claims wherein the
molar ratio of hydrotope: glycol ether is selected to be greater than 1.1: 1.
10. A liquid composition according to any one of the preceding claims wherein the
weight ratio of hydrotope: glycol ether is greater than 1.2: 1.
11. A liquid composition according to any one of the preceding claims wherein the
weight ratio of hydrotope: glycol ether is greater than 1.5: 1.
12. A liquid composition according to any one of the preceding claims in a concentrate
adapted to be diluted for use by at least 20 parts of water to 1 part of the concentrate (100
to 1000 parts of water to 1 part of concentrate in preferred embodiments) and wherein the
hydrotrope is selected from the group comprising of water soluble aromatic sulfonates
with one or more short (C1-C6) side alkyl chains..
13. A liquid composition according to any one of the preceding claims wherein the
solvent comprises in combination at least one glycol ether, at least one polyhydric alcohol,
and water containing boron or borate ions.
14. A liquid composition according to any one of the preceding claims wherein each
component of the composition is selected so as to exclude compounds incorporating an
alkyl chain of longer than six carbons.

15. A liquid composition according to any one of the preceding claims wherein the
weight ratio of hydrotrope to proteolytic enzyme is between 400:1 and 200:1.
16. A liquid composition according to any one of the preceding claims wherein the
weight ratio of hydrotrope to proteolytic enzyme is between 300:1 and 350:1.
17. A liquid composition according to any one of the preceding claims wherein the
concentration of hydrotrope does not exceed 25 %.
18. A liquid composition according to any one of the preceding claims wherein the
molar ratio of glycol ether to polyhydric alcohols is between 0.2:1 and 1:1
19. A liquid composition according to any one of the preceding claims formulated for
use as a medical cleaner.
20. A liquid composition according to any one of claims 1-18 formulated for use as an
industrial cleaner.
21. A liquid composition according to any one of claims 1-18 formulated for use in
cleaning refrigerant coils.
22 A method of cleaning a medical instrument in need thereof comprising he step of
contacting said medical instrument with a composition according to any one of claims 1 to
18
23. A method of cleaning an airconditioning component in need thereof comprising
the step of contacting said airconditioning component with a composition according to any
one of claims 1 to 18.

Liquid compositions for cleaning, in particular medical instruments and air conditioning
surfaces, said composition excluding surfactants and comprising one or more enzymes
including a protease and optionally a hydrolase, a solvent system including a water soluble
glycol ether solvent, at least one anionic hydrotrope, and wherein the molar ratio of said at
least one hydrotrope to said glycol ether in the composition is selected to preserve the
activity of said one or more enzymes. The hydrotrpe is advantageously an anionic
hydrotrope selected from the group consisting of water soluble anionic hydrotropes of the
formula:

and having no alkyl side chain greater than six carbons in length, for example a xylene
sulfonate or cumene sulfonate salt.

Documents:

0612-KOLNP-2009-CORRESPONDENCE-1.5.pdf

612-KOLNP-2009-(01-07-2014)-CORRESPONDENCE.pdf

612-KOLNP-2009-(01-07-2014)-OTHERS.pdf

612-KOLNP-2009-(14-07-2014)-ANNEXURE TO FORM 3.pdf

612-KOLNP-2009-(14-07-2014)-CLAIMS.pdf

612-KOLNP-2009-(14-07-2014)-CORRESPONDENCE.pdf

612-KOLNP-2009-(14-07-2014)-OTHERS.pdf

612-kolnp-2009-abstract.pdf

612-kolnp-2009-CANCELLED PAGES.pdf

612-kolnp-2009-claims.pdf

612-KOLNP-2009-CORRESPONDENCE 1.4.pdf

612-KOLNP-2009-CORRESPONDENCE-1.1.pdf

612-KOLNP-2009-CORRESPONDENCE-1.2.pdf

612-KOLNP-2009-CORRESPONDENCE-1.3.pdf

612-kolnp-2009-CORRESPONDENCE-1.5.pdf

612-kolnp-2009-correspondence.pdf

612-kolnp-2009-description (complete).pdf

612-kolnp-2009-drawings.pdf

612-kolnp-2009-EXAMINATION REPORT.pdf

612-kolnp-2009-form 1.pdf

612-kolnp-2009-FORM 18-1.1.pdf

612-KOLNP-2009-FORM 18.pdf

612-kolnp-2009-form 2.pdf

612-KOLNP-2009-FORM 3-1.1.pdf

612-kolnp-2009-form 3.pdf

612-kolnp-2009-form 5.pdf

612-kolnp-2009-GRANTED-ABSTRACT.pdf

612-kolnp-2009-GRANTED-CLAIMS.pdf

612-kolnp-2009-GRANTED-DESCRIPTION (COMPLETE).pdf

612-kolnp-2009-GRANTED-DRAWINGS.pdf

612-kolnp-2009-GRANTED-FORM 1.pdf

612-kolnp-2009-GRANTED-FORM 2.pdf

612-kolnp-2009-GRANTED-FORM 3.pdf

612-kolnp-2009-GRANTED-FORM 5.pdf

612-kolnp-2009-GRANTED-LETTER PATENT.pdf

612-kolnp-2009-GRANTED-SPECIFICATION-COMPLETE.pdf

612-kolnp-2009-international preliminary examination report.pdf

612-kolnp-2009-INTERNATIONAL PUBLICATION-1.1.pdf

612-kolnp-2009-international publication.pdf

612-kolnp-2009-INTERNATIONAL SEARCH REPORT & OTHERS.pdf

612-kolnp-2009-international search report.pdf

612-kolnp-2009-OTHERS-1.1.pdf

612-KOLNP-2009-OTHERS.pdf

612-kolnp-2009-PA-1.1.pdf

612-KOLNP-2009-PA.pdf

612-kolnp-2009-pct priority document notification.pdf

612-kolnp-2009-pct request form.pdf

612-kolnp-2009-REPLY TO EXAMINATION REPORT.pdf

612-kolnp-2009-specification.pdf

abstract-612-kolnp-2009.jpg


Patent Number 263735
Indian Patent Application Number 612/KOLNP/2009
PG Journal Number 47/2014
Publication Date 21-Nov-2014
Grant Date 18-Nov-2014
Date of Filing 16-Feb-2009
Name of Patentee NOVAPHARM RESEARCH (AUSTRALIA) PTY LTD.
Applicant Address 3-11 PRIMROSE AVENUE, ROSEBERY, NEW SOUTH WALES
Inventors:
# Inventor's Name Inventor's Address
1 SAVAM ALEX 3/124 PADDINGTON STREET, PADDINGTON, NEW SOUTH WALES, 2021
2 KRITZLER, STEVEN 9 REDGUM AVENUE, CRONULLA, NEW SOUTH WALES, 2230
PCT International Classification Number C11D 7/42,A61L 2/18
PCT International Application Number PCT/AU2007/000999
PCT International Filing date 2007-07-18
PCT Conventions:
# PCT Application Number Date of Convention Priority Country
1 2007900582 2007-02-07 Australia
2 2006903863 2006-07-18 Australia